Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL‐10 production

• Published in: International journal of cancer Vol. 94; no. 6; pp. 792 - 794
• Main Authors: Stanczuk, Grazyna A., Sibanda, Elopy N., Perrey, Chris, Chirara, Mike, Pravica, Vera, Hutchinson, Ian V., Tswana, Sam A.
• Format: Journal Article
• Language: English
• Published: New York John Wiley & Sons, Inc 15.12.2001; Wiley-Liss
• Subjects: Adult; Aged; Antineoplastic agents; Biological and medical sciences; cervical cancer; Chemotherapy; Female; Hematologic and hematopoietic diseases; Humans; IL‐10 cytokine gene polymorphisms; Interleukin-10 - biosynthesis; Interleukin-10 - genetics; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Polymorphism, Genetic; Uterine Cervical Neoplasms - genetics; Zimbabwe; Zimbabwe; Africa; Human; Genetic variability; Cytokine; Genotype; Uterine cervix; Malignant tumor; Statistical study; Association; Gene; Risk factor; Interleukin 10; Predisposition; Female; Genetics; Polymorphism
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/ijc.1543

The purpose of our prospective, case‐controlled study was to investigate the hypothesis that women who are genetically programmed to produce high or medium levels of IL‐10 were more likely to develop cancer of the uterine cervix than individuals genetically predisposed to low IL‐10 production. The population was recruited from patients attending gynecological clinics at 2 hospitals in Harare, Zimbabwe. Laboratory tests were performed in the Departments of Immunology, Chemical Pathology and Medical Microbiology, Medical School, University of Zimbabwe, and simultaneously at the Department of Biological Sciences, University of Manchester, United Kingdom. Included in our study were 77 women with histologically proven cancer of the uterine cervix and 69 age‐ and parity‐matched healthy women. All of the patients and healthy controls were from the Shona ethnic group that inhabits northern Zimbabwe. DNA was purified from cervical cytobrush samples obtained from women with cervical cancer. Control DNA was extracted from urine or peripheral blood samples from the healthy women. The Qiagen DNA extraction kit was used. Detection of allele A and/or G at −1082 in the promoter region of the IL‐10 gene was carried out using the ARMS‐PCR technique. Polymorphism in the amplified products was detected by gel electrophoresis in the presence of ethidium bromide and were bands visualized under UV light. The data comprise 77 women who developed invasive cervical cancer and 69 healthy women matched for age and parity. Patients with cancer were significantly (p = 0.001) more likely to be predisposed to produce higher (A/G) levels of IL‐10. The genotype encoding for high (G/G) production of IL‐10 was only observed in one cancer patient. The prevalence of low producers of IL‐10 in the cancer group was significantly lower than in the healthy women. There were no high producers amongst the healthy women. These data suggest that the genetically acquired ability to produce higher levels of IL‐10 may be a significant factor in the development of cervical cancer. © 2001 Wiley‐Liss, Inc.